JNJ-67835989
/ J&J
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
July 21, 2022
A Study of JNJ-67835989 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=109 | Completed | Sponsor: Janssen Research & Development, LLC | Recruiting ➔ Completed | Trial completion date: Oct 2022 ➔ May 2022
Trial completion • Trial completion date
June 22, 2022
A Study of JNJ-67835989 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=150 | Recruiting | Sponsor: Janssen Research & Development, LLC | Trial completion date: Jun 2022 ➔ Oct 2022
Trial completion date
February 03, 2022
A Study of JNJ-67835989 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=129 | Recruiting | Sponsor: Janssen Research & Development, LLC | Trial primary completion date: Jan 2022 ➔ May 2022
Trial primary completion date
June 25, 2021
A Study of JNJ-67835989 in Healthy Participants
(clinicaltrials.gov)
- P1; N=144; Recruiting; Sponsor: Janssen Research & Development, LLC; Trial completion date: Jan 2022 ➔ Jun 2022
Clinical • Trial completion date
May 10, 2021
A Study of JNJ-67835989 in Healthy Participants
(clinicaltrials.gov)
- P1; N=144; Recruiting; Sponsor: Janssen Research & Development, LLC; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open
1 to 5
Of
5
Go to page
1